Prediction and Mechanism of Carbon Nanotube-Induced Fibrosis
Prediction and Mechanism of Carbon Nanotube-Induced Fibrosis
批准号:
8463235
负责人:
Yon Rojanasakul
金额:
$34.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-15 至 2015-05-31
关键词:
1-Phosphatidylinositol 3-KinaseAddressAffectAlveolarAlveolar wallAngiogenic FactorAnimalsBiologicalBiological AssayBiological MarkersBiological ModelsCaliberCarbon NanotubesCell ProliferationCellsCharacteristicsChemicalsChemistryCollagenDevelopmentDiagnosisDiagnosticDiseaseDoseDrug TargetingEarly DiagnosisEarly treatmentEnvironmental and Occupational ExposureEpithelialEvaluationExposure toExtracellular MatrixFibroblastsFibrosisFoundationsGenerationsGoalsGrowth FactorHealthHumanIn VitroIndustrial ProductIndustryInflammationInvestigationKnowledgeLungLung InflammationLung diseasesMediatingMediator of activation proteinMolecular TargetMusNanotechnologyOutcomeOxidation-ReductionPathogenesisPlayProcessProductionPropertyPublic HealthPulmonary FibrosisReactive Oxygen SpeciesRegulationResearch DesignRiskRisk AssessmentRoleScienceSignal PathwaySignal TransductionSolutionsSourceStructure of parenchyma of lungSystemTestingTherapeuticToxic effectTransforming Growth FactorsUnited StatesUnited States National Institutes of HealthVascular Endothelial CellVascular Endothelial Growth Factorsangiogenesisbasecellular targetingcytokinefibrogenesisin vitro Modelin vivointerstitialmouse modelnanomaterialsnanoparticlepublic health relevanceresponsescreeningsingle walled carbon nanotubetrend
中文摘要
描述(由申请人提供):
项目摘要:在过去的几年里,环境和职业对人造纳米材料的暴露显著增加,而且随着新的纳米材料越来越多地被各个行业生产和使用,这一趋势很可能会继续下去。这一趋势引起了人们的极大关注,因为纳米材料对健康的不利影响相对未知和研究不足。最近的研究表明,肺暴露于碳纳米管(CNT)是工业上应用最广泛的纳米材料之一,可导致动物快速和进行性的间质性肺纤维化,而不会引起持续性的肺部炎症,而这通常与其他已知的致纤维化因素有关。碳纳米管的这种不同寻常的纤维化作用引发了重要的健康问题,因为接触碳纳米管可能导致致命的和不可治愈的肺纤维化。我们推测,碳纳米管由于其特殊的尺寸、大的纵横比和化学组成等独特的性质,可以迅速进入肺内,穿透肺泡上皮屏障,并与肺间质成纤维细胞等特定的肺细胞相互作用,诱导纤维增殖和细胞外基质聚集,这是肺纤维化的特征。我们还认为,这种诱导是通过涉及磷脂酰肌醇-3-激酶(PI3K)/Akt激活和氧化还原调节促纤维化和血管生成因子如转化生长因子-β和血管生成因子的信号级联反应来介导的。在目标1中,我们将确定某些纳米颗粒的特性(例如,直径、长径比、分散状态和化学成分)对碳纳米管诱导的肺纤维化的影响,并开发快速的体外筛选试验,可能预测体内的纤维化反应。目的2将描述CNT诱导纤维化的关键信号通路和致纤维化因素,以确定潜在的诊断和治疗该疾病的生物标志物和药物靶点。目的3探讨血管生成和血管生成因子在碳纳米管诱导的肺纤维化中的作用。目的4研究氧化还原对碳纳米管诱导的肝纤维化和血管生成的调节作用,并阐明其可能的机制。通过这一应用,我们希望确定关键的纳米颗粒特性和一套体外筛选试验,以评估纳米颗粒在体内的潜在致纤维化作用。这些信息对于纳米技术的安全使用将是重要的。拟议的研究还将确定早期发现和治疗纳米材料引起的纤维化肺部疾病的分子靶点。
英文摘要
DESCRIPTION (provided by applicant):
Project Summary: Environmental and occupational exposures to manufactured nanomaterials have markedly increased during the past recent years, and in all likelihood this trend will continue as new nanomaterials are being increasingly produced and used by various industries. This trend has been of great concern as the adverse health effects of nanomaterials are relatively unknown and understudied. Recent studies have shown that pulmonary exposure to carbon nanotubes (CNT), one of the most widely used nanomaterials in industry, results in rapid and progressive interstitial lung fibrosis in animals without causing persistent lung inflammation, which is normally associated with other known fibrogenic agents. This unusual fibrogenic effect of CNT raises important health issues since the exposure could result in deadly and incurable lung fibrosis. We hypothesize that CNT, due to their unique properties such as exceptionally small size, large aspect ratio, and chemical composition can rapidly enter the lung, penetrate the alveolar epithelial barrier, and interact with specific lung cells such as interstitial lung fibroblasts to induce fibroproliferation and extracellular matrix accumulation, which are characteristics of lung fibrosis. We also propose that such induction is mediated by signaling cascades that involve phosphatidylinositol-3-kinase(PI3K)/Akt activation and redox regulation of the profibrogenic and angiogenic factors such as TGF-b and VEGF. In Aim 1, we will determine the impact of certain nanoparticle characteristics (e.g., diameter, aspect ratio, dispersion status, and chemistry) on CNT-induced lung fibrosis and develop rapid in vitro screening assays which may be predictive of the in vivo fibrogenic response. Aim 2 will delineate key signaling pathways and fibrogenic factors involved in the induction of fibrosis by CNT in order to identify potential biomarkers and drug targets for diagnosis and treatment of the disease. Aim 3 will investigate the involvement of angiogenesis and angiogenic factors in the development of pulmonary fibrosis induced by CNT. Aim 4 will determine redox regulation of CNT-induced fibrogenesis and angiogenesis and elucidate the underlying mechanisms. Through this application, we expect to define key nanoparticle characteristics and a set of in vitro screening assays for evaluation of the potential fibrogenicity of nanoparticles in vivo. Such information will be important for safe use of nanotechnology. The proposed studies will also identify molecular targets for early detection and treatment of fibrotic lung diseases caused by nanomaterials.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1021/nl2011214
发表时间:
2011-07-13
期刊:
Nano letters
影响因子:
10.8
作者:
[Wang L, Luanpitpong S, Castranova V, Tse W, Lu Y, Pongrakhananon V, Rojanasakul Y]
通讯作者:
Rojanasakul Y
DOI:
10.1186/1743-8977-7-31
发表时间:
2010-10-19
期刊:
Particle and fibre toxicology
影响因子:
10
作者:
[Wang L, Castranova V, Mishra A, Chen B, Mercer RR, Schwegler-Berry D, Rojanasakul Y]
通讯作者:
Rojanasakul Y
Carbon nanotubes induce apoptosis resistance of human lung epithelial cells through FLICE-inhibitory protein.
碳纳米管通过FLICE抑制蛋白诱导人肺上皮细胞凋亡抵抗。
DOI:
10.1093/toxsci/kfu251
发表时间:
2015
期刊:
Toxicological sciences : an official journal of the Society of Toxicology
影响因子:
--
作者:
[Pongrakhananon,Varisa, Luanpitpong,Sudjit, Stueckle,ToddA, Wang,Liying, Nimmannit,Ubonthip, Rojanasakul,Yon]
通讯作者:
Rojanasakul,Yon
DOI:
10.3109/17435390.2011.647929
发表时间:
2013-03
期刊:
Nanotoxicology
影响因子:
5
作者:
[Azad N, Iyer AK, Wang L, Liu Y, Lu Y, Rojanasakul Y]
通讯作者:
Rojanasakul Y
Luciferase reporter cells as a platform to detect SMAD-dependent collagen production.
荧光素酶报告细胞作为检测 SMAD 依赖性胶原蛋白生成的平台。
DOI:
10.1016/j.jbiosc.2014.05.021
发表时间:
2014
期刊:
Journal of bioscience and bioengineering
影响因子:
2.8
作者:
[Lohcharoenkal,Warangkana, Liu,Yuxin, Wang,Liying, Yang,Yong, Rojanasakul,Yon]
通讯作者:
Rojanasakul,Yon
共 8 条
Nanoparticle Fibrogenicity and Fibroblast Stem-Like Cells
-
批准号:9212809
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2016
-
负责人:Yon Rojanasakul
-
依托单位:
Induction of Neoplastic Transformation and Cancer Stem Cells by Carbon Nanotubes
-
批准号:8846114
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2014
-
负责人:Yon Rojanasakul
-
依托单位:
Induction of Neoplastic Transformation and Cancer Stem Cells by Carbon Nanotubes
-
批准号:8691555
-
项目类别:
-
资助金额:$33.49万
-
财政年份:2014
-
负责人:Yon Rojanasakul
-
依托单位:
Induction of Neoplastic Transformation and Cancer Stem Cells by Carbon Nanotubes
-
批准号:9024527
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2014
-
负责人:Yon Rojanasakul
-
依托单位:
Prediction and Mechanism of Carbon Nanotube-Induced Fibrosis
-
批准号:8268403
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2010
-
负责人:Yon Rojanasakul
-
依托单位:
Prediction and Mechanism of Carbon Nanotube-Induced Fibrosis
-
批准号:8111227
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2010
-
负责人:Yon Rojanasakul
-
依托单位:
Prediction and Mechanism of Carbon Nanotube-Induced Fibrosis
-
批准号:7983999
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2010
-
负责人:Yon Rojanasakul
-
依托单位:
Regulation of Fas-Mediated Lung Cell Apoptosis
-
批准号:7838821
-
项目类别:
-
资助金额:$13.65万
-
财政年份:2009
-
负责人:Yon Rojanasakul
-
依托单位:
Regulation of Fas-Mediated Lung Cell Apoptosis
-
批准号:7100360
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2006
-
负责人:Yon Rojanasakul
-
依托单位:
Regulation of Fas-Mediated Lung Cell Apoptosis
-
批准号:7579060
-
项目类别:
-
资助金额:$35.56万
-
财政年份:2006
-
负责人:Yon Rojanasakul
-
依托单位:
Regulation of Fas-Mediated Lung Cell Apoptosis
-
批准号:7373644
-
项目类别:
-
资助金额:$35.56万
-
财政年份:2006
-
负责人:Yon Rojanasakul
-
依托单位:
Regulation of Fas-Mediated Lung Cell Apoptosis
-
批准号:7211462
-
项目类别:
-
资助金额:$35.56万
-
财政年份:2006
-
负责人:Yon Rojanasakul
-
依托单位:
Fas-Induced Apoptosis and Inflammatory Lung Injury
-
批准号:6556065
-
项目类别:
-
资助金额:$14.6万
-
财政年份:2003
-
负责人:Yon Rojanasakul
-
依托单位:
SELECTIVE INHIBITION OF NF-KB MEDIATED GENE EXPRESSION
-
批准号:2881632
-
项目类别:
-
资助金额:$10.95万
-
财政年份:1999
-
负责人:Yon Rojanasakul
-
依托单位:
PULMONARY FIBROTIC CYTOKINE INHIBITION BY ANTISENSE DNA
-
批准号:2232616
-
项目类别:
-
资助金额:$9.87万
-
财政年份:1995
-
负责人:Yon Rojanasakul
-
依托单位:
海外基金